National Institute of Neurological Disorders and Stroke (NINDS)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institute of Neurological Disorders and Stroke (NINDS) sits in the top decile of US sponsors by registered trial count (#61 of 15,742 sponsors by registered trial count).
National Institute of Neurological Disorders and Stroke (NINDS): 567 sponsored US clinical trials, 48 recruiting.
National Institute of Neurological Disorders and Stroke (NINDS) sponsors 567 registered US clinical trials on ClinicalTrials.gov, 48 of them currently recruiting, and 467 completed. 16 of these trials are in Phase 3-4 (later-stage) and 158 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 23 trials.
Top-decile sponsor footprint
National Institute of Neurological Disorders and Stroke (NINDS) ranks in the top decile of sponsors by registered trial count (#61 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
467 of 508 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
567 total, page 7 of 12
Brain Activity in Visual-Motor Behavior
NCT00077038
Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
NCT00076843
Study of Brain Function During Cognitive Tasks
NCT00076739
Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia
NCT00078481
Direct Current Brain Polarization in Frontotemporal Dementia
NCT00077896
Brain Control of Movements in Cerebral Palsy
NCT00076596
Brain Changes Associated With Learning a Motor Task
NCT00076466
Levetiracetam Treatment of L-dopa Induced Dyskinesias
NCT00076674
Enhanced Tactile Memory in the Blind
NCT00076700
Alternative Dosing and Regimen of Replagal to Treat Fabry Disease
NCT00075244
Role of the Right Brain in Recovery of Language Function in Chronic Stroke
NCT00076479
Spinal Reflexes in Motor Skill Learning
NCT00076583
Relationship Between Sensory and Motor Systems in Restless Leg Syndrome
NCT00074672
Spinal Cord Plasticity
NCT00073606
Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors
NCT00075166
Role of the Brain in Processing Visually Presented Objects
NCT00357695
MRI in Autosomal Dominant Partial Epilepsy With Auditory Features
NCT00072813
Improvement of Use Dependent Plasticity in Chronic Stroke Patients
NCT00072735
Classification of Cerebral Palsy Subtypes
NCT00072800
The Physiology of Tricks
NCT00072956
Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
NCT00071838
Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings
NCT00071305
Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast Cancer
NCT00071357
An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease
NCT00071877
Brain Function in Primary Lateral Sclerosis
NCT00071435
Analysis of Brain Metastasis in Patients With Lung Cancer
NCT00071344
An Open-Label Maintenance Study of the Enzyme Replacement Therapy Replagal in Patients With Fabry Disease
NCT00357786
Brain Activation During Simple Vocal Behaviors
NCT00071734
Activating Effects of Sleep Deprivation on Synchronized MEG-EEG Recordings of Epilepsy Patients With Non-Diagnostic EEG
NCT00071370
Analysis of Brain Metastasis in Patients With Breast Cancer, With and Without Over-Expression of HER-2
NCT00071383
Evaluation of Chronic Orthostatic Intolerance
NCT00069693
Improving Motor Learning in Stroke Patients
NCT00067197
Reducing Seizure Frequency Using Cooling of the Head and Neck
NCT00067210
The Effect of Dopamine on Motor Skills Training
NCT00067275
Studying Use-Dependent Plasticity
NCT00067223
Brain Mapping of Voice Control
NCT00066911
Light Scattering Spectroscopy to Determine Brain Tumors
NCT00067418
Investigating Endothelial Precursor Cells (EPCs)
NCT00067067
Modafinil to Treat Fatigue in Post-Polio Syndrome
NCT00067496
Evaluating the Remote Effects of Stroke With MRI and PET Scans
NCT00063180
Investigating the Safety of srTMS in the Treatment of Parkinson's Disease
NCT00063284
Using fMRI to Understand the Roles of Brain Areas for Fine Hand Movements
NCT00063115
Studying Automatic Movements in Patients With Parkinson's Disease
NCT00063661
Stimulating Deep Brain Regions With a Magnetic Stimulator
NCT00063245
Measuring Levels of SMN in Blood Samples of SMA Patients
NCT00061607
Investigating the Cognitive Processes That Underlie Social Knowledge and Behavior
NCT00061334
Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)
NCT00061373
Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance
NCT00060866
Magnetic Resonance Imaging of Calculus Problem Solving
NCT00060658
MRI Study of Self-Perception of Postural Stability
NCT00060593
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 78 |
| Phase 3 | 11 |
| Phase 4 | 5 |
Therapeutic Areas
What is open in the National Institute of Neurological Disorders and Stroke (NINDS) pipeline
48 recruiting of 567 indexed (8% open); 467 completed (82%).
Phase mix: 16 late (III/IV) vs 158 early (I/II) (early-phase heavy).
Top condition: Healthy (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institute of Neurological Disorders and Stroke (NINDS): open-pipeline peers nationwide
Peers matched on 567 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
National Institute of Neurological Disorders and Stroke (NINDS) sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 567 trials (± recruiting share)
- Children's Hospital Medical Center, Cincinnati · 571 trials · 19% recruiting
- University of Maryland, Baltimore · 560 trials · 18% recruiting
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
Sponsors near 8% open enrollment (± trial volume)
- National Jewish Health · 8% recruiting · 83 trials
- ACADIA Pharmaceuticals · 9% recruiting · 35 trials
- Texas Tech University Health Sciences Center, El Paso · 9% recruiting · 35 trials
- Boehringer Ingelheim · 8% recruiting · 515 trials
Related
What to do with this National Institute of Neurological Disorders and Stroke (NINDS) page
567 registered trials is a research-attention snapshot, not an endorsement of National Institute of Neurological Disorders and Stroke (NINDS) or any single study.
- 48 of National Institute of Neurological Disorders and Stroke (NINDS)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition National Institute of Neurological Disorders and Stroke (NINDS) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. National Institute of Neurological Disorders and Stroke (NINDS) pipeline card: 567 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.